MedTrace Logo

Evaluation of the Effect of a Probiotic Supplement Upon Gastrointestinal Function

NCT02928484 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2016-10-10

No results posted yet for this study

Summary

The purpose of this pilot study is to evaluate whether a probiotic supplement improves gastrointestinal (GI) function.

Conditions

  • Signs and Symptoms, Digestive
  • Dyspepsia

Interventions

DIETARY_SUPPLEMENT

Probiotic mix CBP-004019/C

One capsule per day of the probiotic mix CBP-004019/C during one month.

DIETARY_SUPPLEMENT

Placebo

One capsule per day of the placebo (maltodextrin) during one month.

Sponsors & Collaborators

  • Hospital Universitario Central de Asturias

    collaborator OTHER

  • National Research Council, Spain

    collaborator OTHER_GOV

  • Biopolis S.L.

    lead INDUSTRY

Principal Investigators

  • Adolfo Suárez, MD, PhD · Hospital Universitario Central de Asturias, Servicio de Gastroenterología

  • Miguel Gueimonde, PhD · Consejo Superior de Investigaciones Científicas, IPLA-CSIC

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2017-06-30
Completion
2017-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02928484 on ClinicalTrials.gov